VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140,016 | -71.4% | 14,943 | -25.2% | 0.01% | -70.7% |
| Q2 2023 | $489,889 | -69.9% | 19,971 | -71.5% | 0.04% | -58.6% |
| Q1 2023 | $1,628,621 | +22.0% | 69,988 | +32.7% | 0.10% | +12.5% |
| Q4 2022 | $1,334,824 | +20.1% | 52,739 | -8.5% | 0.09% | +20.5% |
| Q3 2022 | $1,111,000 | -8.7% | 57,642 | +20.7% | 0.07% | +12.3% |
| Q2 2022 | $1,217,000 | +208.1% | 47,771 | +211.4% | 0.06% | +209.5% |
| Q1 2022 | $395,000 | -27.5% | 15,339 | +17.9% | 0.02% | -36.4% |
| Q4 2021 | $545,000 | -8.9% | 13,014 | -5.2% | 0.03% | -2.9% |
| Q3 2021 | $598,000 | -3.7% | 13,734 | +4.6% | 0.03% | +3.0% |
| Q2 2021 | $621,000 | +7.6% | 13,125 | +16.7% | 0.03% | 0.0% |
| Q1 2021 | $577,000 | +42.8% | 11,250 | -25.5% | 0.03% | +13.8% |
| Q4 2020 | $404,000 | -77.4% | 15,094 | -71.1% | 0.03% | -50.0% |
| Q3 2020 | $1,791,000 | – | 52,171 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |